Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,224 total articles
Freshworks Inc. releases a report detailing how mid-market companies lose on average 25% of their AI budgets to complexity overhead before achieving returns, with increased workload and integration challenges delaying ROI realization. Despite these hurdles, most mid-market organizations plan to increase AI investments, focusing on AI solutions that…
Annexon, Inc., a biopharmaceutical company focused on targeted immunotherapies for neuroinflammatory diseases, announced that CEO Douglas Love will participate in investor conferences in June 2026 to discuss company progress and strategy. Live webcasts of presentations will be available online.
Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on inhaled therapies for serious respiratory diseases, announced that its management will present an overview of the company at the Jefferies Global Healthcare Conference. The presentation will cover Avalyn's development of inhaled formulations of antifibrotic drugs targeting pu…
Pacira BioSciences reports real-world study findings showing that use of EXPAREL, their non-opioid pain therapy, in outpatient total shoulder arthroplasty patients led to reduced opioid use, fewer opioid-related adverse events, and lower healthcare costs compared to standard analgesia. These findings support the expanding role of non-opioid pain ma…
Mission Produce, Inc., a leading global supplier of fresh Hass avocados and other produce, will release its fiscal second quarter 2026 financial results after market close on June 8, 2026. The company will also hold a conference call and webcast to discuss the results.
GrowGeneration Corp., a major supplier of specialty products for controlled environment agriculture and commercial cultivation, announced its management team's upcoming participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026. CEO Darren Lampert and CFO Gregory Sanders will engage in a Fireside Chat an…
BioVie Inc., a clinical-stage biopharmaceutical company, is hosting a live investor webinar to discuss its investigational oral drug bezisterim for neurological conditions including Parkinson's, Alzheimer's, and Long COVID, as well as progress on BIV201 for advanced liver disease. The company emphasizes the therapeutic potential and multi-billion-d…
Abacus Global Management has entered into a strategic alliance with Manning & Napier, including a minority equity investment of approximately $53 million. This partnership leverages Abacus's proprietary longevity data and actuarial expertise alongside Manning & Napier's wealth management platform, aiming to create enhanced lifespan-based financial …
Cogent Biosciences announced its participation in the Jefferies Global Healthcare Conference scheduled for June 3, 2026, including a live webcast of the presentation. Additionally, the company disclosed inducement equity award grants to six new employees under Nasdaq governance rules, comprising stock options and restricted stock units, to incentiv…
Provident Bank has promoted Jessica Dudick to Senior Vice President, Team Leader of the Monmouth/Ocean Commercial & Industrial lending team. Dudick will manage relationship managers and lending specialists focused on small- to mid-sized business lending and deposit/treasury solutions in New Jersey. She brings over 20 years of experience and will le…
Mineralys Therapeutics, a biopharmaceutical company focused on developing treatments for hypertension and related diseases, announced its management team will participate in the Jefferies 2026 Global Healthcare Conference. They will deliver a corporate presentation, which will be webcast live.
Erasca, Inc., a clinical-stage precision oncology company focused on RAS/MAPK pathway-driven cancers, announced its participation in the Jefferies Global Healthcare Conference. Management will present during a fireside chat and conduct investor meetings, with live and archived webcasts available through the company's website.
NewcelX Ltd., a clinical-stage regenerative medicine company, announced submission of a Pre-IND briefing package to the FDA supporting clinical trial initiation of NCEL-101 combined with tegoprubart for treating type 1 diabetes. The planned therapy aims at enabling durable graft survival without calcineurin inhibitors, potentially offering a functi…
HCW Biologics Inc. has exercised its option to regain exclusive ex vivo commercial rights to two advanced immunotherapeutic reagents, HCW9206 and HCW9201, from Wugen Inc. These reagents show promise for reducing CAR-T therapy manufacturing costs while improving efficacy by enriching long-lived T memory stem cells, potentially enabling more potent a…
VenHub Global, Inc. has opened its second, larger production and assembly facility in Las Vegas, significantly increasing its capacity to manufacture autonomous Smart Stores. This expansion supports faster delivery to meet growing commercial interest and builds on recent strategic agreements, including partnerships with LAX/Metro and Circa Resort &…
Fusion Fuel Green PLC released an investor update video and presentation detailing its strategic progress, financial targets for 2026 and 2027, and plans to acquire up to 100% of Royal Uranium. The company announced an Extraordinary General Meeting for June 8, 2026, to vote on the Royal Uranium acquisition, preferred shares conversion, and a propos…
Allot Ltd., a global provider of cybersecurity and network intelligence solutions, announced management will meet one-on-one with institutional investors during the William Blair Growth Stock Conference from June 2-4, 2026, in Chicago. The company offers comprehensive Security-as-a-Service and network platforms deployed worldwide across service pro…
Avis Budget Group announced its intention to issue $300 million in additional 8% senior notes due 2031 through a private offering. The proceeds, along with existing cash, will be used to redeem part of their 5.75% senior notes due 2027. The offering targets qualified institutional buyers under Rule 144A and is guaranteed by Avis Budget and some US …
FTI Consulting, Inc. announces the appointment of Damon Yousefy as Senior Managing Director in its Transactions practice, focusing on restructuring and bankruptcy tax. With extensive experience in distressed M&A and tax issues, Yousefy's addition is expected to bolster FTI's capabilities to support clients facing financial distress amid geopolitica…
Papa John's International, Inc. announced a global collaboration with Disney and Pixar to celebrate the release of Toy Story 5 in June 2026. The campaign includes themed personal pizzas, limited-edition collectibles, a special in-app game, and a custom-animated Pixar spot. Available in Canada and 42 international markets, this strategic partnership…
Abercrombie & Fitch Co. announced record first quarter net sales of $1.1 billion, a 2% increase from last year, marking the 14th consecutive quarter of growth. Growth was driven by the Americas and strong expansion in the Asia-Pacific region, while Europe, Middle East, and Africa (EMEA) experienced a 10% sales decline, notably impacted by Middle Ea…
Medline Inc. announced that its executive leadership team will participate in the William Blair and Goldman Sachs investor conferences in early June 2026, where they will present company insights and updates. Webcasts of these presentations will be available on Medline's Investor Relations website.
Abundia Global Impact Group, Inc. announces significant progress in its commercialization strategy for converting waste plastics and biomass into low-carbon fuels and chemicals. Key developments include securing Burns & McDonnell as lead engineer for front-end design, licensing Topsoe's HydroFlex® technology, acquiring project developer RPD Technol…
BridgeBio Pharma announced that the FDA has accepted its NDA for BBP-418 with Priority Review for treatment of limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9), with a PDUFA date set for November 27, 2026. BBP-418 demonstrated strong efficacy in clinical trials, showing improvement in treated patients across key endpoints, and could become the…
Context Therapeutics Inc., a clinical-stage biopharmaceutical company specializing in T cell engaging bispecific antibodies for solid tumors, announced its upcoming presentation at the Jefferies Global Healthcare Conference on June 3, 2026. The company also disclosed granting stock options to a new employee as an inducement to join the company, wit…
